Autoantibody microarrays for biomarker discovery

Abstract

Identification of autoantigens and the detection of autoantibody reactivity are useful in biomarker discovery and for explaining the role of important biochemical pathways in disease. Despite all of their potential advantages, the main challenge to working with autoantibodies is their sensitivity. Nevertheless, proteomics may hold the key to overcoming this limitation by providing the means to multiplex. Clearly, the ability to detect multiple autoantigens using a platform such as a high-density antigen microarray would improve sensitivity and specificity of detection for autoantibody profiling. The aims of this review are to: briefly describe the current status of antigen–autoantibody microarrays; provide examples of their use in biomarker discoveries; address current limitations; and provide examples and strategies to facilitate their implementation in the clinical setting.

Keywords::

• autoantibody
• autoantigen
• biomarker
• microarray
• multiplex platform

Acknowledgements

This work was supported in part by grants U01DK063665 and R01DK066020 from the National Institutes of Health to Brian CS Liu.